Brief: Surmodics Shares Data From 160 Patients In PROWL Registry Using Pounce For Real-World Limb Ischemia

SurModics

04/11/2025 11:22

Nov 4 (Reuters) - Surmodics Inc SRDX.O:

SURMODICS ANNOUNCES OUTCOMES FROM 160 PATIENTS IN PROWL REGISTRY EVALUATING POUNCE™ THROMBECTOMY PLATFORM IN TREATMENT OF REAL-WORLD LIMB ISCHEMIA PRESENTATIONS

SURMODICS INC - PROCEDURAL SUCCESS 91.7%, DEVICE-RELATED ADVERSE EVENTS 0.6%

SURMODICS INC - 94.8% PATIENTS EXPERIENCED POST-PROCEDURAL BLOOD FLOW RESTORATION

SURMODICS INC - DEVICE TECHNICAL SUCCESS 83.2% WITH <50% RESIDUAL OBSTRUCTION

Source text: ID:nBw8g5ZYda

Further company coverage: SRDX.O

 ((Reuters.Briefs@thomsonreuters.com;))